v3.26.3
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit) - USD ($)
Preferred Stock
Common Stock
Common Stock Issuable
Additional Paid-in capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 790 $ 3,033,013 $ (4,391,924) $ (1,358,121)
Balance (in Shares) at Dec. 31, 2024 790,385      
Net loss   (402,397) (402,397)
Balance at Mar. 31, 2025 $ 790 3,033,013 (4,794,321) (1,760,518)
Balance (in Shares) at Mar. 31, 2025 790,385      
Balance at Dec. 31, 2024 $ 790 3,033,013 (4,391,924) (1,358,121)
Balance (in Shares) at Dec. 31, 2024 790,385      
Net loss           (4,845,845)
Balance at Sep. 30, 2025 $ 1,258 17,397,163 (9,237,769) 8,160,652
Balance (in Shares) at Sep. 30, 2025 1,257,598      
Balance at Mar. 31, 2025 $ 790 3,033,013 (4,794,321) (1,760,518)
Balance (in Shares) at Mar. 31, 2025 790,385      
Stock-based compensation 192,053 192,053
Common stock grants $ 100 1,699,900 1,700,000
Common stock grants (in Shares) 100,000      
Conversion of convertible notes into common stock $ 30 499,192 499,222
Conversion of convertible notes into common stock (in Shares) 29,713      
IPO representative warrants 139,388 139,388
IPO common stock issuance, net $ 338 11,629,389 11,629,727
IPO common stock issuance, net (in Shares) 337,500      
Net loss (2,662,193) (2,662,193)
Balance at Jun. 30, 2025 $ 1,258 17,192,935 (7,456,514) 9,737,679
Balance (in Shares) at Jun. 30, 2025 1,257,598      
Stock-based compensation 42,674 42,674
Issuance of advisor warrants in connection with IPO 161,554 161,554
Net loss (1,781,255) (1,781,255)
Balance at Sep. 30, 2025 $ 1,258 17,397,163 (9,237,769) 8,160,652
Balance (in Shares) at Sep. 30, 2025 1,257,598      
Balance at Dec. 31, 2025 $ 748 $ 1,258 163,738,882 (10,393,061) 153,347,827
Balance (in Shares) at Dec. 31, 2025 747,702 1,257,598      
Issuance of common stock under advisory agreement $ 8,113,318 8,113,318
Issuance of common stock under advisory agreement (in Shares) 455,804      
Stock-based compensation 114,166 114,166
Net loss (35,059,852) (35,059,852)
Balance at Mar. 31, 2026 $ 748 $ 1,258 $ 8,113,318 163,853,048 (45,452,913) 126,515,459
Balance (in Shares) at Mar. 31, 2026 747,702 1,257,598 455,804      
Balance at Dec. 31, 2025 $ 748 $ 1,258 163,738,882 (10,393,061) 153,347,827
Balance (in Shares) at Dec. 31, 2025 747,702 1,257,598      
Net loss           (21,586,816)
Balance at Sep. 30, 2026 $ 748 $ 1,848 $ 3,636,262 168,863,992 (31,979,877) 140,522,973
Balance (in Shares) at Sep. 30, 2026 747,702 1,847,626 204,284      
Balance at Mar. 31, 2026 $ 748 $ 1,258 $ 8,113,318 163,853,048 (45,452,913) 126,515,459
Balance (in Shares) at Mar. 31, 2026 747,702 1,257,598 455,804      
Issuance of common stock under advisory agreement $ 251 $ (4,477,056) 4,476,805
Issuance of common stock under advisory agreement (in Shares) 251,520 (251,520)      
Stock-based compensation 105,210 105,210
Subscription receivable collected on subsidiary shares 1,002 1,002
Net loss   (20,173,130) (20,173,130)
Balance at Jun. 30, 2026 $ 748 $ 1,509 $ 3,636,262 168,436,065 (65,626,043) 106,448,541
Balance (in Shares) at Jun. 30, 2026 747,702 1,509,118 204,284      
Stock-based compensation 7,624 7,624
Reversal of stock-based compensation on forfeited options (8,675) (8,675)
Common stock issued for fractional-share round-ups in reverse stock split $ 34 (34)
Common stock issued for fractional-share round-ups in reverse stock split (in Shares) 33,506        
Conversion of convertible notes into common stock $ 305 429,012 429,317
Conversion of convertible notes into common stock (in Shares) 305,002        
Net loss 33,646,166 33,646,166
Balance at Sep. 30, 2026 $ 748 $ 1,848 $ 3,636,262 $ 168,863,992 $ (31,979,877) $ 140,522,973
Balance (in Shares) at Sep. 30, 2026 747,702 1,847,626 204,284